Published in Arthritis Rheum on August 01, 2001
Mesenchymal stem cells: biology, pathophysiology, translational findings, and therapeutic implications for cardiac disease. Circ Res (2011) 4.75
Adult mesenchymal stem cells and cell-based tissue engineering. Arthritis Res Ther (2002) 2.63
Stem cell therapy for liver disease: parameters governing the success of using bone marrow mesenchymal stem cells. Gastroenterology (2008) 2.31
Bone tissue engineering: recent advances and challenges. Crit Rev Biomed Eng (2012) 2.27
Skeletal muscle repair by adult human mesenchymal stem cells from synovial membrane. J Cell Biol (2003) 1.99
Evidence for tissue-resident mesenchymal stem cells in human adult lung from studies of transplanted allografts. J Clin Invest (2007) 1.87
A novel in vivo murine model of cartilage regeneration. Age and strain-dependent outcome after joint surface injury. Osteoarthritis Cartilage (2008) 1.87
Bone marrow and umbilical cord blood human mesenchymal stem cells: state of the art. Int J Clin Exp Med (2010) 1.53
Regeneration of intervertebral disc by mesenchymal stem cells: potentials, limitations, and future direction. Eur Spine J (2006) 1.51
Mesenchymal stem cell-based therapy: a new paradigm in regenerative medicine. J Cell Mol Med (2009) 1.49
The immunomodulatory activity of human umbilical cord blood-derived mesenchymal stem cells in vitro. Immunology (2008) 1.46
Joint morphogenetic cells in the adult mammalian synovium. Nat Commun (2017) 1.46
Bone regeneration and stem cells. J Cell Mol Med (2011) 1.41
The natural and engineered 3D microenvironment as a regulatory cue during stem cell fate determination. Tissue Eng Part B Rev (2009) 1.37
Role of paracrine factors in stem and progenitor cell mediated cardiac repair and tissue fibrosis. Fibrogenesis Tissue Repair (2008) 1.37
Transcriptional profiles discriminate bone marrow-derived and synovium-derived mesenchymal stem cells. Arthritis Res Ther (2005) 1.37
Immunomodulatory properties of mesenchymal stem cells: a review based on an interdisciplinary meeting held at the Kennedy Institute of Rheumatology Division, London, UK, 31 October 2005. Arthritis Res Ther (2007) 1.35
Concise review: MicroRNA expression in multipotent mesenchymal stromal cells. Stem Cells (2007) 1.32
Mesenchymal stem cells in joint disease and repair. Nat Rev Rheumatol (2013) 1.31
Natural history of mesenchymal stem cells, from vessel walls to culture vessels. Cell Mol Life Sci (2013) 1.31
Activation of WNT and BMP signaling in adult human articular cartilage following mechanical injury. Arthritis Res Ther (2006) 1.31
Identification of subpopulations with characteristics of mesenchymal progenitor cells from human osteoarthritic cartilage using triple staining for cell surface markers. Arthritis Res Ther (2004) 1.30
Tissue engineering of articular cartilage with biomimetic zones. Tissue Eng Part B Rev (2009) 1.30
Adipose-Derived Stem Cells (ADSC) and Aesthetic Surgery: A Mini Review. World J Plast Surg (2013) 1.28
Mesenchymal stem cell-based therapies in regenerative medicine: applications in rheumatology. Stem Cell Res Ther (2011) 1.28
Adult mesenchymal stem cells and cell surface characterization - a systematic review of the literature. Open Orthop J (2011) 1.27
Collection, cryopreservation, and characterization of human dental pulp-derived mesenchymal stem cells for banking and clinical use. Tissue Eng Part C Methods (2008) 1.26
Biological treatment strategies for disc degeneration: potentials and shortcomings. Eur Spine J (2006) 1.25
Gene expression profiling in the synovium identifies a predictive signature of absence of response to adalimumab therapy in rheumatoid arthritis. Arthritis Res Ther (2009) 1.23
Isolation, culture and evaluation of multilineage-differentiating stress-enduring (Muse) cells. Nat Protoc (2013) 1.21
Differential survival of leukocyte subsets mediated by synovial, bone marrow, and skin fibroblasts: site-specific versus activation-dependent survival of T cells and neutrophils. Arthritis Rheum (2006) 1.20
Mesenchymal progenitor cells derived from traumatized human muscle. J Tissue Eng Regen Med (2009) 1.20
Role of mesenchymal stromal cells in solid organ transplantation. Transplant Rev (Orlando) (2008) 1.17
Comparison of potentials of stem cells isolated from tendon and bone marrow for musculoskeletal tissue engineering. Tissue Eng Part A (2011) 1.16
Novel strategies in tendon and ligament tissue engineering: Advanced biomaterials and regeneration motifs. Sports Med Arthrosc Rehabil Ther Technol (2010) 1.14
Bone-marrow-derived mesenchymal stem cells for organ repair. Stem Cells Int (2013) 1.14
Chondrogenesis of mesenchymal stem cells: role of tissue source and inducing factors. Stem Cell Res Ther (2010) 1.14
Mesenchymal stem/stromal cells: a new ''cells as drugs'' paradigm. Efficacy and critical aspects in cell therapy. Curr Pharm Des (2013) 1.13
Enhanced osteoclast development in collagen-induced arthritis in interferon-gamma receptor knock-out mice as related to increased splenic CD11b+ myelopoiesis. Arthritis Res Ther (2004) 1.10
Toll-like receptors as modulators of mesenchymal stem cells. Front Immunol (2012) 1.09
Mesenchymal stem cells isolated from adipose and other tissues: basic biological properties and clinical applications. Stem Cells Int (2012) 1.09
Reduced reactivation from dormancy but maintained lineage choice of human mesenchymal stem cells with donor age. PLoS One (2011) 1.08
A comparison of the functionality and in vivo phenotypic stability of cartilaginous tissues engineered from different stem cell sources. Tissue Eng Part A (2012) 1.08
Mesenchymal stem cells as a potent cell source for bone regeneration. Stem Cells Int (2012) 1.06
Stem cells in clinical practice: applications and warnings. J Exp Clin Cancer Res (2011) 1.06
Characterization of adipocyte differentiation from human mesenchymal stem cells in bone marrow. BMC Dev Biol (2010) 1.06
Implantation of allogenic synovial stem cells promotes meniscal regeneration in a rabbit meniscal defect model. J Bone Joint Surg Am (2012) 1.05
Mesenchymal stem cell and regenerative medicine: regeneration versus immunomodulatory challenges. Am J Stem Cells (2013) 1.05
Protein synthesis and secretion in human mesenchymal cells derived from bone marrow, adipose tissue and Wharton's jelly. Stem Cell Res Ther (2014) 1.05
Adipose mesenchymal stem cells in the field of bone tissue engineering. World J Stem Cells (2014) 1.05
Umbilical cord blood-derived mesenchymal stem cells inhibit, but adipose tissue-derived mesenchymal stem cells promote, glioblastoma multiforme proliferation. Stem Cells Dev (2013) 1.04
Mesenchymal stem cells, autoimmunity and rheumatoid arthritis. QJM (2014) 1.04
In search of mechanisms associated with mesenchymal stem cell-based therapies for acute kidney injury. Clin Biochem Rev (2013) 1.02
Stem cells and cartilage development: complexities of a simple tissue. Stem Cells (2010) 1.02
Biological properties of mesenchymal Stem Cells from different sources. Muscles Ligaments Tendons J (2012) 1.01
Optimising human mesenchymal stem cell numbers for clinical application: a literature review. Stem Cells Int (2012) 1.00
Targets, models and challenges in osteoarthritis research. Dis Model Mech (2015) 0.99
Effect of in vitro passaging on the stem cell-related properties of tendon-derived stem cells-implications in tissue engineering. Stem Cells Dev (2011) 0.99
Metabolic programming of mesenchymal stromal cells by oxygen tension directs chondrogenic cell fate. Proc Natl Acad Sci U S A (2014) 0.99
Alterations in the self-renewal and differentiation ability of bone marrow mesenchymal stem cells in a mouse model of rheumatoid arthritis. Arthritis Res Ther (2010) 0.98
Potential of human umbilical cord blood mesenchymal stem cells to heal damaged corneal endothelium. Mol Vis (2012) 0.98
Deterministic and stochastic approaches in the clinical application of mesenchymal stromal cells (MSCs). Front Cell Dev Biol (2014) 0.98
Relevance of the stroma and epithelial-mesenchymal transition (EMT) for the rheumatic diseases. Arthritis Res Ther (2006) 0.97
Proteomic definitions of mesenchymal stem cells. Stem Cells Int (2011) 0.96
Chondrogenesis by chemotactic homing of synovium, bone marrow, and adipose stem cells in vitro. FASEB J (2011) 0.96
Rheumatoid arthritis synovial fibroblasts produce a soluble form of the interleukin-7 receptor in response to pro-inflammatory cytokines. J Cell Mol Med (2011) 0.96
Morphological characterization of intra-articular HMGB1 expression during the course of collagen-induced arthritis. Arthritis Res Ther (2007) 0.96
Chondrogenic differentiation of mesenchymal stem cells: challenges and unfulfilled expectations. Tissue Eng Part B Rev (2014) 0.96
Osteoblasts derived from osteophytes produce interleukin-6, interleukin-8, and matrix metalloproteinase-13 in osteoarthritis. J Bone Miner Metab (2009) 0.95
Ovalbumin sensitization and challenge increases the number of lung cells possessing a mesenchymal stromal cell phenotype. Respir Res (2010) 0.95
Human adipose-derived stem cells impair natural killer cell function and exhibit low susceptibility to natural killer-mediated lysis. Stem Cells Dev (2011) 0.95
Proliferation as a requirement for in vitro chondrogenesis of human mesenchymal stem cells. Stem Cells Dev (2012) 0.94
Human palatine tonsil: a new potential tissue source of multipotent mesenchymal progenitor cells. Arthritis Res Ther (2008) 0.94
Detection of oncofetal h19 RNA in rheumatoid arthritis synovial tissue. Am J Pathol (2003) 0.94
Further proof of the plasticity of adult stem cells and their role in tissue repair. J Cell Biol (2003) 0.94
Mechanical regulation of chondrogenesis. Stem Cell Res Ther (2013) 0.93
Interleukin-1 beta and tumor necrosis factor alpha inhibit migration activity of chondrogenic progenitor cells from non-fibrillated osteoarthritic cartilage. Arthritis Res Ther (2013) 0.93
Mechanisms of T-cell immunosuppression by mesenchymal stromal cells: what do we know so far? Biomed Res Int (2014) 0.92
Genetic mismatch affects the immunosuppressive properties of mesenchymal stem cells in vitro and their ability to influence the course of collagen-induced arthritis. Arthritis Res Ther (2012) 0.92
Current research on pharmacologic and regenerative therapies for osteoarthritis. Bone Res (2016) 0.92
Epigenetic regulation of osteogenic and chondrogenic differentiation of mesenchymal stem cells in culture. Cell J (2013) 0.91
Differential properties of human ACL and MCL stem cells may be responsible for their differential healing capacity. BMC Med (2011) 0.91
Isolation and characterization of multipotential mesenchymal cells from the mouse synovium. PLoS One (2012) 0.91
Are MSCs angiogenic cells? New insights on human nestin-positive bone marrow-derived multipotent cells. Front Cell Dev Biol (2014) 0.91
Bone regeneration: the stem/progenitor cells point of view. J Cell Mol Med (2009) 0.90
Activin A expression regulates multipotency of mesenchymal progenitor cells. Stem Cell Res Ther (2010) 0.90
Leukemia inhibitory factor secretion is a predictor and indicator of early progenitor status in adult bone marrow stromal cells. Tissue Eng Part A (2009) 0.90
Cell-based approaches to joint surface repair: a research perspective. Osteoarthritis Cartilage (2013) 0.89
Preclinical studies on mesenchymal stem cell-based therapy for growth plate cartilage injury repair. Stem Cells Int (2011) 0.89
Identification of appropriate reference genes for human mesenchymal cells during expansion and differentiation. PLoS One (2013) 0.88
Genetically modified mesenchymal stem cells for improved islet transplantation. Mol Pharm (2011) 0.88
Hypoxia. HIF-mediated articular chondrocyte function: prospects for cartilage repair. Arthritis Res Ther (2009) 0.88
Current perspectives in mesenchymal stem cell therapies for osteoarthritis. Stem Cells Int (2014) 0.88
Stem cell therapies for knee cartilage repair: the current status of preclinical and clinical studies. Am J Sports Med (2013) 0.88
Neurorestoration induced by mesenchymal stem cells: potential therapeutic mechanisms for clinical trials. Yonsei Med J (2012) 0.88
CD14-negative isolation enhances chondrogenesis in synovial fibroblasts. Tissue Eng Part A (2009) 0.87
Stimulatory effects of distinct members of the bone morphogenetic protein family on ligament fibroblasts. Ann Rheum Dis (2005) 0.87
TGF-ß1 enhances the BMP-2-induced chondrogenesis of bovine synovial explants and arrests downstream differentiation at an early stage of hypertrophy. PLoS One (2013) 0.87
Superficial cells are self-renewing chondrocyte progenitors, which form the articular cartilage in juvenile mice. FASEB J (2016) 0.87
Osteogenic potential of human periosteum-derived progenitor cells in PLGA scaffold using allogeneic serum. J Zhejiang Univ Sci B (2006) 0.86
SIP1, a novel zinc finger/homeodomain repressor, interacts with Smad proteins and binds to 5'-CACCT sequences in candidate target genes. J Biol Chem (1999) 3.35
Frzb, a secreted protein expressed in the Spemann organizer, binds and inhibits Wnt-8. Cell (1997) 2.40
Recommendations for standardization and phenotype definitions in genetic studies of osteoarthritis: the TREAT-OA consortium. Osteoarthritis Cartilage (2010) 2.39
Identification of multiple active growth factors in basement membrane Matrigel suggests caution in interpretation of cellular activity related to extracellular matrix components. Exp Cell Res (1992) 2.38
Disruption of human limb morphogenesis by a dominant negative mutation in CDMP1. Nat Genet (1997) 2.38
A human chondrodysplasia due to a mutation in a TGF-beta superfamily member. Nat Genet (1996) 2.11
Mutations in CDMP1 cause autosomal dominant brachydactyly type C. Nat Genet (1997) 2.06
Cartilage-derived morphogenetic proteins. New members of the transforming growth factor-beta superfamily predominantly expressed in long bones during human embryonic development. J Biol Chem (1994) 2.03
Mechanisms of GDF-5 action during skeletal development. Development (1999) 1.83
Molecular markers predictive of the capacity of expanded human articular chondrocytes to form stable cartilage in vivo. Arthritis Rheum (2001) 1.71
Primary structure and tissue distribution of FRZB, a novel protein related to Drosophila frizzled, suggest a role in skeletal morphogenesis. J Biol Chem (1996) 1.70
Human periosteum-derived cells maintain phenotypic stability and chondrogenic potential throughout expansion regardless of donor age. Arthritis Rheum (2001) 1.69
Single, intra-articular treatment with 6 ml hylan G-F 20 in patients with symptomatic primary osteoarthritis of the knee: a randomised, multicentre, double-blind, placebo controlled trial. Ann Rheum Dis (2010) 1.45
The cysteine-rich frizzled domain of Frzb-1 is required and sufficient for modulation of Wnt signaling. Proc Natl Acad Sci U S A (1997) 1.45
Isolation of markers for chondro-osteogenic differentiation using cDNA library subtraction. Molecular cloning and characterization of a gene belonging to a novel multigene family of integral membrane proteins. J Biol Chem (1996) 1.42
Extracellular matrix protein 1 (ECM1) has angiogenic properties and is expressed by breast tumor cells. FASEB J (2001) 1.42
Role of CDMP-1 in skeletal morphogenesis: promotion of mesenchymal cell recruitment and chondrocyte differentiation. J Cell Biol (1999) 1.42
Stimulation of the expression of osteogenic and chondrogenic phenotypes in vitro by osteogenin. Proc Natl Acad Sci U S A (1989) 1.34
Differentiation of canalicular cell processes in bone cells by basement membrane matrix components: regulation by discrete domains of laminin. Cell (1990) 1.33
Ankylosing enthesitis, dactylitis, and onychoperiostitis in male DBA/1 mice: a model of psoriatic arthritis. Ann Rheum Dis (2004) 1.21
Cartilage-derived morphogenetic proteins and osteogenic protein-1 differentially regulate osteogenesis. J Bone Miner Res (1998) 1.20
Increased expression of nerve growth factor (NGF) and high affinity NGF receptor (p140 TrkA) in human osteoarthritic chondrocytes. Rheumatology (Oxford) (2002) 1.19
Induction of nephrogenic mesenchyme by osteogenic protein 1 (bone morphogenetic protein 7). Proc Natl Acad Sci U S A (1996) 1.17
The C-terminal domain of Mad-like signal transducers is sufficient for biological activity in the Xenopus embryo and transcriptional activation. Mech Dev (1997) 1.15
Cloning and expression of the Wnt antagonists Sfrp-2 and Frzb during chick development. Dev Biol (2000) 1.14
Expression pattern of osteogenic protein-1 (bone morphogenetic protein-7) in human and mouse development. J Histochem Cytochem (1995) 1.07
Differentiation-dependent alternative splicing and expression of the extracellular matrix protein 1 gene in human keratinocytes. J Invest Dermatol (2000) 1.05
Presence of cartilage-derived morphogenetic proteins in articular cartilage and enhancement of matrix replacement in vitro. Arthritis Rheum (1998) 1.04
Cartilage-derived morphogenetic protein-1 and -2 are endogenously expressed in healthy and osteoarthritic human articular chondrocytes and stimulate matrix synthesis. Osteoarthritis Cartilage (2002) 1.04
Expression pattern of two Frizzled-related genes, Frzb-1 and Sfrp-1, during mouse embryogenesis suggests a role for modulating action of Wnt family members. Dev Dyn (1998) 1.02
Recombinant human extracellular matrix protein 1 inhibits alkaline phosphatase activity and mineralization of mouse embryonic metatarsals in vitro. Bone (2001) 1.01
Interleukin-10 and interleukin-10 receptor in human osteoarthritic and healthy chondrocytes. Clin Exp Rheumatol (2001) 1.01
Inhibition of osteoclasts does not prevent joint ankylosis in a mouse model of spondyloarthritis. Rheumatology (Oxford) (2008) 0.99
Current views on calcium phosphate osteogenicity and the translation into effective bone regeneration strategies. Acta Biomater (2012) 0.97
Morphological and immunocytochemical characterization of cultured fibroblast-like cells derived from adult human synovial membrane. Arch Histol Cytol (2003) 0.97
Evidence for a differential association of the Arg200Trp single-nucleotide polymorphism in FRZB with hip osteoarthritis and osteoporosis. Rheumatology (Oxford) (2005) 0.96
The bone morphogenetic protein 2 signaling mediator Smad1 participates predominantly in osteogenic and not in chondrogenic differentiation in mesenchymal progenitors C3H10T1/2. J Bone Miner Res (2000) 0.95
Developing human lung and kidney are major sites for synthesis of bone morphogenetic protein-3 (osteogenin). J Histochem Cytochem (1994) 0.94
Effects of cartilage-derived morphogenetic proteins and osteogenic protein-1 on osteochondrogenic differentiation of periosteum-derived cells. Endocrinology (2001) 0.92
Proteoglycan metabolism is age related and modulated by isoforms of platelet-derived growth factor in bovine articular cartilage explant cultures. Arch Biochem Biophys (1993) 0.92
Melanoma inhibitory activity, a biomarker related to chondrocyte anabolism, is reversibly suppressed by proinflammatory cytokines in rheumatoid arthritis. Ann Rheum Dis (2008) 0.92
A clinically relevant model of osteoinduction: a process requiring calcium phosphate and BMP/Wnt signalling. J Cell Mol Med (2009) 0.91
The history of osteoarthritis-osteoarthrosis. Ann Rheum Dis (2008) 0.89
Osteogenin inhibits proliferation and stimulates differentiation in mouse osteoblast-like cells (MC3T3-E1). Biochem Biophys Res Commun (1990) 0.89
Molecular cloning, characterization, and genetic mapping of the cDNA coding for a novel secretory protein of mouse. Demonstration of alternative splicing in skin and cartilage. J Biol Chem (1995) 0.88
In vitro growth rate of fibroblast-like synovial cells is reduced by methotrexate treatment. Ann Rheum Dis (2003) 0.87
Stimulatory effects of cartilage-derived morphogenetic proteins 1 and 2 on osteogenic differentiation of bone marrow stromal cells. Cytokine (2000) 0.87
Bovine articular chondrocytes do not undergo hypertrophy when cultured in the presence of serum and osteogenic protein-1. Biochem Biophys Res Commun (1993) 0.86
Molecular signaling in bone fracture healing and distraction osteogenesis. Histol Histopathol (1999) 0.86
Inflammatory factors in the circulation of patients with active rheumatoid arthritis stimulate osteoclastogenesis via endogenous cytokine production by osteoblasts. Osteoporos Int (2014) 0.86
Skeletal tissue engineering: opportunities and challenges. Best Pract Res Clin Rheumatol (2001) 0.84
High density micromass cultures of a human chondrocyte cell line: a reliable assay system to reveal the modulatory functions of pharmacological agents. Biochem Pharmacol (2011) 0.84
Osteogenic protein-1 promotes growth and maturation of chick sternal chondrocytes in serum-free cultures. J Cell Sci (1995) 0.83
Smad-interacting protein 1 is a repressor of liver/bone/kidney alkaline phosphatase transcription in bone morphogenetic protein-induced osteogenic differentiation of C2C12 cells. J Biol Chem (2001) 0.83
Decreased levels of nucleotide pyrophosphatase phosphodiesterase 1 are associated with cartilage calcification in osteoarthritis and trigger osteoarthritic changes in mice. Ann Rheum Dis (2012) 0.82
Calcium signaling in endothelin- and platelet-derived growth factor-stimulated chondrocytes. J Bone Miner Res (1994) 0.82
Osteogenin promotes reexpression of cartilage phenotype by dedifferentiated articular chondrocytes in serum-free medium. Exp Cell Res (1991) 0.82
Activation of nuclear factor kappa B and mitogen activated protein kinases in psoriatic arthritis before and after etanercept treatment. Clin Exp Rheumatol (2008) 0.81
Animal models in systemic sclerosis. Clin Exp Rheumatol (2008) 0.80
Does tranexamic acid stabilised fibrin support the osteogenic differentiation of human periosteum derived cells? Eur Cell Mater (2011) 0.79
Dynamic mRNA distribution pattern of thyroid hormone transporters and deiodinases during early embryonic chicken brain development. Neuroscience (2012) 0.79
Pyoderma gangrenosum developing during therapy with TNF-alpha antagonists in a patient with rheumatoid arthritis. Clin Rheumatol (2007) 0.79
Deletion of frizzled-related protein reduces voluntary running exercise performance in mice. Osteoarthritis Cartilage (2008) 0.78
Niemann-Pick disease type B: an unusual clinical presentation with multiple vertebral fractures. Am J Med Genet (2002) 0.78
In vitro repair potential of articular cartilage: proteoglycan metabolism in the different areas of the femoral condyles in human cartilage explants. J Rheumatol (1987) 0.78
Molecular cloning of a highly conserved mouse and human integral membrane protein (Itm1) and genetic mapping to mouse chromosome 9. Genomics (1996) 0.78
Mesenchymal differentiation propensity of a human embryonic stem cell line. Cell Prolif (2011) 0.78
TGF-beta and basement membrane matrigel stimulate the chondrogenic phenotype in osteoblastic cells derived from fetal rat calvaria. J Bone Miner Res (1996) 0.78
Activation and localization of cartilage-derived morphogenetic protein-1 at the site of ossification of the ligamentum flavum. Eur Spine J (2001) 0.77
Repair function in organ cultured human cartilage. Replacement of enzymatically removed proteoglycans during longterm organ culture. J Rheumatol (1985) 0.77
Evaluation of mouse Sfrp3/Frzb1 as a candidate for the lst, Ul, and Far mutants on chromosome 2. Mamm Genome (1998) 0.77
Interleukin-10 in rheumatoid arthritis. Clin Exp Rheumatol (1996) 0.76
Assignment of a new TGF-beta superfamily member, human cartilage-derived morphogenetic protein-1, to chromosome 20q11.2. Genomics (1996) 0.76
Osteoprotegerin and osteoprotegerin-ligand balance: a new paradigm in bone metabolism providing new therapeutic targets. Clin Rheumatol (2001) 0.76
The combined mechanism of bone morphogenetic protein- and calcium phosphate-induced skeletal tissue formation by human periosteum derived cells. Eur Cell Mater (2016) 0.76
Initiation of bone development by osteogenin and promotion by growth factors. Connect Tissue Res (1989) 0.76
Detection, identification and in vivo treatment responsiveness of bone morphogenetic protein (BMP)-activated cell populations in the synovium of patients with rheumatoid arthritis. Ann Rheum Dis (2008) 0.76
Rheumatic disorders and glucocorticoid-induced osteoporosis. Front Horm Res (2002) 0.76
Bone densitometry is not a good predictor of hip fracture. BMJ (2001) 0.75
Isolated thrombocytopenia associated with low dose methotrexate therapy. Clin Rheumatol (1997) 0.75
Progress towards a molecular basis for joint surface repair. Osteoarthritis Cartilage (2009) 0.75
Transforming growth factor-beta: its effect on phenotype reexpression by dedifferentiated chondrocytes in the presence and absence of osteogenin. In Vitro Cell Dev Biol (1992) 0.75
Carpal tunnel syndrome: a review. Clin Rheumatol (1997) 0.75
Relationships between translation of pro alpha1(I) and pro alpha2(I) mRNAs during synthesis of the type I procollagen heterotrimer. J Cell Biochem (1995) 0.75
Caspase inhibition supports proper gene expression in ex vivo mouse limb cultures. Cell Death Differ (2001) 0.75
Reparative response of human articular cartilage in tissue culture. Comparison between a normal and an osteoarthritic knee of the same donor. Clin Exp Rheumatol (1987) 0.75
Absence of GDF5 does not interfere with LPS Toll-like receptor signaling. Clin Exp Rheumatol (2009) 0.75
Changes in contact area characteristics of the ankle after a cartilage biopsy at the postero-medial rim of the talar dome. Osteoarthritis Cartilage (2009) 0.75
Repeatability and contact stress gradient detection of sealed pressure-sensitive film when used in a physiological joint model. Proc Inst Mech Eng H (2008) 0.75